Commonly used reporting guidelines
| STROBE | Observational Studies |
| PRISMA | Systematic reviews of trials |
| PRISMA-P | Systematic review protocols |
| CONSORT | Randomised trials |
| SPIRIT | Randomised trial protocols |
| SRQR | Qualitative Research |
| CARE | Case Reports |
| STARD | Diagnostic studies |
| TRIPOD+AI | Prediction Models |
| ARRIVE | Animal Research |
| SQUIRE | Quality Improvement |
| CHEERS | Economic Evaluations |
| Search all |
Full bibliographic reference
Provenzano E, Bossuyt V, Viale G, Cameron D, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Boughey J, Curigliano G, Dixon JM, Esserman L, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Symmans WF; Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration. Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group. Mod Pathol. 2015;28(9):1185-1201.
Language
English
Study design
Clinical trials, Experimental studies
Clinical area
Oncology, Pathology
Applies to the whole report or to individual sections of the report?
Intervention (exposure), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions
Record last updated on
October 21, 2016